A citation-based method for searching scientific literature

Xin-An Wang, Ran Zhang, Zhi-Gang She, Xiao-Fei Zhang, Ding-Sheng Jiang, Tao Wang, Lu Gao, Wei Deng, Shu-Min Zhang, Li-Hua Zhu, Sen Guo, Ke Chen, Xiao-Dong Zhang, De-Pei Liu, Hongliang Li. Hepatology 2014
Times Cited: 106



Rebecca G Baker, Matthew S Hayden, Sankar Ghosh. Cell Metab 2011
Times Cited: 1206




List of shared articles



Times cited

Liver macrophages and inflammation in physiology and physiopathology of non-alcoholic fatty liver disease.
Ronan Thibaut, Matthew C Gage, Inès Pineda-Torra, Gwladys Chabrier, Nicolas Venteclef, Fawaz Alzaid. FEBS J 2022
16

Hepatic IRF3 fuels dysglycemia in obesity through direct regulation of Ppp2r1b.
Suraj J Patel, Nan Liu, Sam Piaker, Anton Gulko, Maynara L Andrade, Frankie D Heyward, Tyler Sermersheim, Nufar Edinger, Harini Srinivasan, Margo P Emont,[...]. Sci Transl Med 2022
3

Recent Advances in Understanding the Role of IKKβ in Cardiometabolic Diseases.
Rebecca Hernandez, Changcheng Zhou. Front Cardiovasc Med 2021
6

Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases.
Jingjing Cai, Meng Xu, Xiaojing Zhang, Hongliang Li. Annu Rev Pathol 2019
43

Innate Immune Signaling and Its Role in Metabolic and Cardiovascular Diseases.
Meng Xu, Peter P Liu, Hongliang Li. Physiol Rev 2019
42

Nontranscriptional Activity of Interferon Regulatory Factor 3 Protects Mice From High-Fat Diet-Induced Liver Injury.
Carlos Sanz-Garcia, Megan R McMullen, Saurabh Chattopadhyay, Sanjoy Roychowdhury, Ganes Sen, Laura E Nagy. Hepatol Commun 2019
10

Suppression of NF-κB activation by PDLIM2 restrains hepatic lipogenesis and inflammation in high fat diet induced mice.
Ya-Rong Hao, Feng-Juan Tang, Xue Zhang, Hui Wang. Biochem Biophys Res Commun 2018
9

Role of Innate Immune Signaling in Non-Alcoholic Fatty Liver Disease.
Jingjing Cai, Xiao-Jing Zhang, Hongliang Li. Trends Endocrinol Metab 2018
44

Chronic inflammation-elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance.
Xiao-Feng Li, Cheng Chen, Dai-Min Xiang, Le Qu, Wen Sun, Xin-Yuan Lu, Teng-Fei Zhou, Shu-Zhen Chen, Bei-Fang Ning, Zhuo Cheng,[...]. Hepatology 2017
71

USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity.
Shimin An, Ling-Ping Zhao, Li-Jun Shen, Siyuan Wang, Kuo Zhang, Yu Qi, Jilin Zheng, Xiao-Jing Zhang, Xue-Yong Zhu, Rong Bao,[...]. Hepatology 2017
32

DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity.
Lanfeng Xie, Pi-Xiao Wang, Peng Zhang, Xiao-Jing Zhang, Guang-Nian Zhao, Aibing Wang, Junhong Guo, Xueyong Zhu, Qin Zhang, Hongliang Li. J Hepatol 2016
46

Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis.
Ling Gao, Pi-Xiao Wang, Yaxing Zhang, Chang-Jiang Yu, Yanxiao Ji, Xiaozhan Wang, Peng Zhang, Xi Jiang, Hong Jin, Zan Huang,[...]. J Hepatol 2016
36

Inflamed macrophage microvesicles induce insulin resistance in human adipocytes.
Yaqin Zhang, Li Shi, Hongliang Mei, Jiexin Zhang, Yunxia Zhu, Xiao Han, Dalong Zhu. Nutr Metab (Lond) 2015
51

Interferon regulatory factor signalings in cardiometabolic diseases.
Xiao-Jing Zhang, Peng Zhang, Hongliang Li. Hypertension 2015
39